Clinical Trial Update: Study of Botulinum Toxin Type A (BOTOX®) to Treat Urinary Incontinence From Neurogenic Detrusor Overactivity in Belgium

View source ↗

Summary

A completed clinical trial evaluating Botulinum Toxin Type A (BOTOX) for urinary incontinence due to neurogenic detrusor overactivity in Belgium; results posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurogenic Detrusor Overactivity
• Urinary Incontinence

Drugs mentioned

• Botox (OnabotulinumtoxinA)

Snippet

Sponsor: Allergan | Conditions: Urinary Incontinence | Status: COMPLETED | Results posted: 2017-12-15